Burning Rock Biotech Limited
BNR
$23.00
$0.251.10%
NASDAQ
| 09/30/2025 | 03/31/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -0.35% | -5.76% | -5.76% | -10.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -0.35% | -5.76% | -5.76% | -10.56% |
| Cost of Revenue | -- | -13.17% | -13.44% | -13.44% | -9.25% |
| Gross Profit | -- | 5.89% | -2.09% | -2.09% | -11.15% |
| SG&A Expenses | -- | -41.00% | -35.14% | -35.14% | -27.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -35.29% | -31.77% | -31.77% | -27.14% |
| Operating Income | -- | 65.33% | 52.68% | 52.68% | 40.01% |
| Income Before Tax | -- | 60.67% | 48.61% | 48.61% | 40.88% |
| Income Tax Expenses | -- | 175.52% | 143.77% | 143.77% | -49.93% |
| Earnings from Continuing Operations | -- | 59.81% | 47.91% | 47.91% | 40.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 59.81% | 47.91% | 47.91% | 40.92% |
| EBIT | -- | 65.33% | 52.68% | 52.68% | 40.01% |
| EBITDA | -- | 75.14% | 62.06% | 62.06% | 49.39% |
| EPS Basic | -- | 60.12% | 48.13% | 48.13% | 41.02% |
| Normalized Basic EPS | -- | 85.01% | 70.21% | 70.21% | 55.85% |
| EPS Diluted | -- | 60.12% | 48.13% | 48.13% | 41.02% |
| Normalized Diluted EPS | -- | 85.01% | 70.21% | 70.21% | 55.85% |
| Average Basic Shares Outstanding | -- | 1.72% | 0.52% | 0.52% | 0.29% |
| Average Diluted Shares Outstanding | -- | 1.72% | 0.52% | 0.52% | 0.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |